Institutional investors purchased a net $290.0 thousand shares of PURE during the quarter ended January 2015 and now own 2.70% of the total shares outstanding. This is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN CAPITAL MANAGEMENT, INC. Bought 250.0 Thousand shares of PURE Biosciences Inc
SENTINEL CAPITAL SOLUTIONS, INC. Bought 40.0 Thousand shares of PURE Biosciences Inc